The most common adverse reaction is eye pain, reported in approximately 16% of patients. Other less frequent adverse drug reactions include visual acuity reduction (10.7%), ocular hyperemia (6.7%), ocular inflammation (5.3%), tearing (5.3%), corneal deposits (4%), cataracts (4%), and foreign body sensation (2.7%). Mild to moderate eye discomfort is expected; however, patients should notify their ophthalmologist or health care professional if more serious eye reactions occur.

Adverse events were not observed in animal reproduction studies. Additionally, there are no known significant drug interactions. Ophthalmic cenegermin is not expected to cause any adverse effects in breastfed infants.